ArticleFrontiers in immunology2025

Glypican 3-targeted chimeric antigen receptor T cells secreting TROP2-directed bispecific T cell engagers exhibit potent efficacy against lung squamous cell carcinoma.

Lianjie Ruan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.